Gerresheimer (ETR:GXI) stock price target increased to 73.00EUR, issued a research note today by Deutsche Bank AG
- Updated: October 3, 2016
In a report released on 10/03/2016 Deutsche Bank AG increased the stock price target of Gerresheimer (ETR:GXI) to 73.00EUR indicating a possible downside of -0.04%.
Yesterday Gerresheimer (ETR:GXI) traded 0.00% even at 75.65EUR. The company’s 50-day moving average is 0.00EUR and its 200-day moving average is 0.00EUR. The last closing price is up 0.00% from the 200-day moving average, compared to the S&P 500 which has decreased -0.01% over the same time period. 0 shares of the stock traded hands, down from an average trading volume of 0
See Chart Below
Gerresheimer has a 52 week low of 0.00EUR and a 52 week high of 0.00EUR The company’s market cap is currently 0 EUR.
General Information About Gerresheimer (ETR:GXI)
Gerresheimer AG is a Germany-based company that operates in the pharmaceuticals and health care industry. It is structured in three business segments: Plastic and Devices, Primary Packaging Glass and Life Science Research. The Company produces pharmaceutical packaging products, as well as drug-delivery systems made out of glass and plastics or a combination of both. Its product portfolio includes insulin pens, inhalers, pre-fillable syringes, vials, ampoules, bottles and containers for liquid and solid pharmaceuticals with closure and safety systems, plus cosmetic packaging products. The Company operates approximately 40 production facilities in Europe, North America, South America and Asia.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.